000 | 01438 a2200397 4500 | ||
---|---|---|---|
005 | 20250517160849.0 | ||
264 | 0 | _c20180402 | |
008 | 201804s 0 0 eng d | ||
022 | _a2047-4881 | ||
024 | 7 |
_a10.1177/2047487317706586 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSchiele, François | |
245 | 0 | 0 |
_aCoronary artery disease: Risk stratification and patient selection for more aggressive secondary prevention. _h[electronic resource] |
260 |
_bEuropean journal of preventive cardiology _c06 2017 |
||
300 |
_a88-100 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aBiomarkers _xblood |
650 | 0 | 4 |
_aBlood Coagulation _xdrug effects |
650 | 0 | 4 |
_aBlood Platelets _xdrug effects |
650 | 0 | 4 |
_aCoronary Artery Disease _xblood |
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 |
_aDyslipidemias _xblood |
650 | 0 | 4 |
_aFibrinolytic Agents _xadverse effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypolipidemic Agents _xadverse effects |
650 | 0 | 4 |
_aLipids _xblood |
650 | 0 | 4 | _aPatient Selection |
650 | 0 | 4 | _aRecurrence |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aSecondary Prevention _xmethods |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aEcarnot, Fiona | |
700 | 1 | _aChopard, Romain | |
773 | 0 |
_tEuropean journal of preventive cardiology _gvol. 24 _gno. 3_suppl _gp. 88-100 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1177/2047487317706586 _zAvailable from publisher's website |
999 |
_c27281703 _d27281703 |